Neogen

Neogen Corp. engages in the development, manufacture, and sale of products dedicated to food and animal safety. It operates through the following segments: Food Safety and Animal Safety. The Food Safety segment consists of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, drug residues, and levels of general sanitation. The Animal Safety segment includes a line of consumable products marketed to veterinarians and animal health product distributors. The company was founded on June 30, 1981 and is headquartered in Lansing, MI.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Neogen reports robust Q2 earnings, targets $1B revenue by 2025

Neogen's Q2 2023 earnings call highlighted impressive revenue growth, improved margins, and strategic focus on integration and customer service.
While facing challenges related to increased debt levels and operational complexities, Neogen aims for ambitious revenue and EBITDA targets by 2025.
The company's performance underscores its potential for continued success in the Food Safety and Animal Safety segments through organic growth and financial discipline.

Neogen reports robust Q3 earnings, focuses on data analytics growth

Neogen's Q3 performance reflects strong revenue growth and strategic focus on data analytics for food security. While challenges exist in certain business segments, the company remains optimistic about long-term opportunities and integration synergies.

Neogen reports stellar Q4 results, eyes growth through integration

Neogen's Q4 2023 earnings call highlighted robust financial performance, successful integration of acquired divisions, and strategic outlook for fiscal '24. The company's focus on growth, innovation, and market expansion positions it well for continued success in the food safety and animal health sectors.

Neogen reports robust Q1 earnings, eyes growth amid regional challenges

Neogen's Q1 2024 showed strong revenue growth but faced challenges in core revenue.
The company highlighted progress in key segments like Food Safety and genomics.
Efficiency issues from ERP implementation impacted revenue timing.
Management remains optimistic about the full-year outlook despite regional challenges.

Neogen reports flat Q2 revenues, focuses on integration and market challenges

Neogen's Q2 performance was mixed, with strengths in certain segments and challenges in others. The company remains optimistic about its long-term prospects despite market headwinds.

Neogen reports improved margins in Q3 despite integration challenges

Neogen's Q3 2024 performance showed improvements in gross margin and EBITDA, but challenges with shipping inefficiencies and integration impacted revenue growth. The company is focused on resolving operational inefficiencies and regaining lost customers to achieve long-term growth goals.

Neogen reports Q4 revenue growth but faces EBITDA margin decline

Neogen's Q4 showed mixed performance with revenue growth but declining EBITDA margins.
The company faces challenges in the soft food safety end market and supply constraints.
However, Neogen is focusing on innovation and underpenetrated markets for future growth.

Neogen reports Q1 revenue decline, focuses on food safety growth

Neogen's Q1 performance showed mixed results with revenue decline and EBITDA pressure.
The company's strengths lie in its strategic positioning in food safety and customer-focused approach.
Challenges persist in certain segments, requiring operational adjustments for sustained growth.
Identified opportunities in geographic expansion and strategic investments can drive future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Neogen Corp. engages in the provision of development, manufacture, and marketing of food and animal safety products. It operates through the Food Safety and Animal Safety segments. The Food Safety segment consists of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, drug residues, and levels of general sanitation. The Animal Safety segment includes a line of consumable products marketed to veterinarians and animal health product distributors. The company was founded on June 30, 1981 and is headquartered in Lansing, MI.

Revenue of $229.0 million, an increase of 73.0% over the prior-year quarter. Net income of $1.5 million; $0.01 per diluted share.

Neogen Announces First-Quarter 2024 Results

Neogen Corporation (NASDAQ:NEOG), a specialist in food safety solutions, is set to unveil its first-quarter earnings Tuesday (Oct 10) with investors expecting a quiet start to the new financial year. The Lansing, Michigan-based company, which has been a trailblazer in detecting harmful substances in food since 1982, is expected to post earnings of 2.5 cents a share, exactly half the figure achieved in the same period last year.

Neogen set make a quiet start to new financial year

Investors are optimistic about Neogen (NEOG), led by progress in the Food Safety business and recent product launches.

Here's Why You Should Invest in Neogen (NEOG) Stock Now

Within the biosecurity portfolio, Neogen (NEOG) continues to record solid growth in cleaners, disinfectants and rodenticides.

Neogen (NEOG) Gains From Strong Segmental Sales, Innovation

LANSING, Mich. , Sept. 26, 2023 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) will issue its first-quarter earnings release before the opening of the market on Tuesday, October 10, 2023.

Neogen Announces First-Quarter Earnings Release Date

Neogen (NEOG) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Down -12.39% in 4 Weeks, Here's Why Neogen (NEOG) Looks Ripe for a Turnaround

Neogen's animal safety division had the weakest numbers. The company said its legacy food safety revenue is expected to rise in the low single digits.

Why Shares of Neogen Are Slumping This Week

Neogen (NEOG) introduces the latest solution in the SureKill brand of products, SureKill Evolve SC.

Neogen (NEOG) Launches SureKill Evolve SC Pest Management Tool

LEXINGTON, Ky. , Sept. 1, 2023 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) announced today that it has released SureKill® Evolve SC, the newest professional pest management solution in the SureKill line.

Neogen® Releases New Professional Pest Management Solution

LANSING, Mich. , Aug. 31, 2023 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) announced today that the Company will participate in the 2023 Wells Fargo Healthcare Conference in Boston, Massachusetts, on Thursday, September 7.

Neogen® To Participate in 2023 Wells Fargo Healthcare Conference

LEXINGTON, Ky. , Aug. 30, 2023 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) announced today that its K-Blue® Luminescent ONE has won the 2023 Best Innovative Luminol-Based Substrate award at the International Life Sciences Awards 2023.

Neogen® Wins Best Innovative Luminol-Based Substrate Award

Corporacion America Airports

Shake Shack

The year 2021 was the time of the meme stock. Companies like GameStop (NYSE: GME ) saw their share prices surge to previously unthinkable heights as traders leaned heavily into short-squeeze stocks.

3 Short Squeeze Stocks up 50% or More in 2023

Neogen's (NEOG) new Igenity Enhanced Dairy offers farmers valid data and assesses their herd's potential. It helps them make the most informed decisions.

Neogen (NEOG) Introduces New Genomic Data Management Tool

LINCOLN, Neb. , Aug. 15, 2023 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that it has launched Igenity® Enhanced Dairy, a new and progressive genomic data management tool.

Neogen® Launches Igenity® Enhanced Dairy

Definitive Healthcare Corp

Patterson Companies

Medical Product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how NEOG, PDCO and DH are poised ahead of their earnings release.

3 Medical Product Stocks Set to Outpace Q2 Earnings Estimates

LINCOLN, Neb. , Aug. 8, 2023 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) announced today that it has released an extensive selection of new genetic tests through Paw Print Genetics® and Canine HealthCheck® solutions.

Neogen® Unveils Over 100 New Genetic Tests

Neogen (NEOG) Q4 fiscal 2023 results reflect core growth in both operating segments despite softening market conditions.

Neogen (NEOG) Q4 Earnings Beat Estimates, Gross Margin Up

Neogen (NEOG) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.10 per share. This compares to earnings of $0.18 per share a year ago.

Neogen (NEOG) Q4 Earnings and Revenues Top Estimates

Revenue of $241.8 million, an increase of 72.6% over the prior-year quarter. Net income of $5.6 million; $0.03 per diluted share.

Neogen Announces Fourth-Quarter 2023 Results

Neogen (NEOG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Neogen (NEOG) Q4 Earnings Expected to Decline

OPKO Health

Procore Technologies

NEOG, OPK and PCOR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 19, 2023.

Best Momentum Stocks to Buy for July 19th

Neogen Corporation's shares have risen 36% since my last report. Despite strong Q3 figures and a 70% YoY revenue increase, I'm still cautious on returns on capital and profitability downstream. Investor sentiment for Neogen is currently low, with no upward revisions to earnings or revenue estimates made by Wall Street in the last 3 months.

Neogen: Fundamentals Unmatched To Latest Market Rally, Reiterate Hold

Neogen (NEOG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

What Makes Neogen (NEOG) a New Buy Stock

Neogen (NEOG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Earnings Estimates Moving Higher for Neogen (NEOG): Time to Buy?

Neogen (NEOG) receives the prestigious 2023 Red Dot Award for the Petrifilm Plate Reader Advanced in Design category.

News for Neogen Stock (NEOG)